Teva Launches Generic Abilify® Tablets in the United States

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Teva Launches Generic Abilify® Tablets in the United States

Teva Pharma (TEVA) Announces U.S. Launch of Generic Abilify; Remains in Patent Litigation with Otsuka

April 28, 2015 3:22 PM EDT

Teva Pharma (NYSE: TEVA) announced the launch of the generic equivalent to Abilify (aripiprazole) Tablets, 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg, in the United States. Aripiprazole tablets, an atypical antipsychotic medication, are approved for the treatment of schizophrenia and for the acute treatment of manic and mixed episodes associated with bipolar I disorder.

Our commitment at Teva is to make affordable, high-quality generic medicines available to millions of patients every day. We are pleased to launch... More